Showing results (1-10 of 16) with videos related to

Sort By:
Pageof 2
Molecular Cancer Research : MCR|October 27, 2020
The Paradoxical Roles of Orphan Nuclear Receptor 4A (NR4A) in CancerStephen Safe, Keshav Karki
Biological Chemistry|December 23, 2017
Metformin-induced anticancer activities: recent insightsStephen Safe, Vijayalekshmi Nair, Keshav Karki
Molecular Pharmacology|August 18, 2018
Bortezomib Targets Sp Transcription Factors in Cancer CellsKeshav Karki, Sneha Harishchandra, Stephen Safe
Gynecologic Oncology|May 5, 2019
Nuclear receptor 4A1 (NR4A1) antagonists induce ROS-dependent inhibition of mTOR signaling in endometrial cancerKumaravel Mohankumar, Xi Li, Subhashree Sridharan, et al.
Biochemical and Biophysical Research Communications|May 15, 2018
Inhibition of pancreatic cancer Panc1 cell migration by omeprazole is dependent on aryl hydrocarbon receptor activation of JNKUn-Ho Jin, Keshav Karki, Sang-Bae Kim, et al.
Cancer Prevention Research (Philadelphia, Pa.)|July 5, 2017
Piperlongumine Induces Reactive Oxygen Species (ROS)-Dependent Downregulation of Specificity Protein Transcription FactorsKeshav Karki, Erik Hedrick, Ravi Kasiappan, et al.
American Journal of Cancer Research|August 15, 2022
Short chain fatty acids exhibit selective estrogen receptor downregulator (SERD) activity in breast cancerAbigail Schoeller, Keshav Karki, Arul Jayaraman, et al.
Cancers|June 2, 2021
NR4A1 Ligands as Potent Inhibitors of Breast Cancer Cell and Tumor GrowthKeshav Karki, Kumaravel Mohankumar, Abigail Schoeller, et al.
Molecular Cancer Research : MCR|January 6, 2019
Reactive Oxygen Species (ROS)-Inducing Triterpenoid Inhibits Rhabdomyosarcoma Cell and Tumor Growth through Targeting Sp Transcription FactorsRavi Kasiappan, Indira Jutooru, Kumaravel Mohankumar, et al.
Pageof 2